Overcoming gastric acid degradation with advanced acid-resistant polymer matrix shells, targeted intestinal release kinetics, and USP <711> validated dissolution performance for global nutraceutical brands.
In global dietary supplement commerce, active bio-nutrients such as viable probiotic strains, systemic proteolytic enzymes (Nattokinase, Serrapeptase), S-Adenosylmethionine (SAM-e), Reduced Glutathione, and volatile essential oils face a destructive physiological barrier: the harsh, acidic environment of the human stomach. Gastric juice maintains a low pH between 1.0 and 2.5, filled with pepsin enzymes designed to denature proteins and break down complex organic compounds.
Standard two-piece gelatin or immediate-release Hydroxypropyl Methylcellulose (HPMC) capsules dissolve within 5 to 15 minutes post-ingestion. When gastric-sensitive compounds are released prematurely into the stomach, bio-activity drops drastically—often resulting in over 90% destruction of live probiotic colony-forming units (CFUs) or complete inactivation of metabolic enzymes. Furthermore, releasing pungent or irritating active ingredients like garlic extract, iron salts, or oregano oil directly into the gastric mucosal lining causes reflux, burping, and digestive distress for consumers.
Delayed Release Capsules (also referred to as acid-resistant capsules or targeted intestinal delivery capsules) solve these formulation challenges by engineering a temporal or pH-dependent delay into the dissolution profile. At Bactolac Pharmaceutical, our R&D chemists leverage next-generation acid-resistant polymers—such as low-moisture HPMC combined with natural pectin, gellan gum, or hypromellose phthalate-free matrices—to ensure the capsule remains completely intact in gastric fluid (pH 1.2) for up to 120 minutes before dissolving rapidly upon entering the neutral-to-alkaline duodenum and ileum (pH 5.5 to 6.8).
Understanding the kinetic dissolution behavior of different capsule shells under United States Pharmacopeia testing protocols is essential for brand owners, procurement teams, and product developers selecting the ideal delivery system.
| Delivery System Type | Primary Polymer Composition | Disintegration in Gastric Fluid (pH 1.2, 2 Hrs) | Dissolution in Intestinal Fluid (pH 6.8, 45 Min) | Clean Label Status | Target Payload Applications |
|---|---|---|---|---|---|
| Standard Gelatin Capsule | Bovine / Porcine Gelatin Matrix | Complete Dissolution (5–15 Minutes) | N/A (Already Disintegrated) | Traditional | Non-sensitive vitamins, minerals, basic herbal powders |
| Standard HPMC Capsule | Pure Hydroxypropyl Methylcellulose | Complete Dissolution (10–20 Minutes) | N/A (Already Disintegrated) | Vegetarian / Non-GMO | Water-soluble vitamins, anti-caking herbal formulas |
| Acid-Resistant HPMC (DRcaps® Type) | HPMC with High-Viscosity Pectin / Gellan Gum | Intact (Zero Rupture for 30–120 Mins) | Complete Release (>85% within 45 Mins) | 100% Clean-Label Plant Polymer | Probiotics, enzymes, SAM-e, Glutathione, GLP-1 support blends |
| Polymer Enteric-Coated Capsule | Gelatin/HPMC + Methacrylic Copolymer / CAP Coating | 100% Intact (Strict Zero Dissolution) | Rapid Triggered Release at pH >5.5 | Pharma-Grade / Requires Coating Step | Targeted colonic active delivery, heavy oil suspensions, APIs |
We provide full-service custom contract manufacturing, formulation development, and private label execution tailored to specific retail performance criteria, regional regulatory requirements, and stability targets.
Engineered using a dual-polymer matrix of HPMC and slow-dissolving plant carbohydrates. Requires no organic solvent coating steps, rendering it 100% vegetarian, non-GMO, Kosher, and Halal certified while shielding stomach-sensitive formulas.
Utilizes precision spray-coating technology to apply food-grade, phthalate-free enteric polymers over filled two-piece capsules. Solves severe stomach degradation and eliminates fishy or pungent reflux entirely.
Encapsulate an inner delayed-release capsule containing sensitive enzymes inside an outer immediate-release liquid capsule containing fatty acids. Enables duel-phase kinetic release profiles in a single single-serving dose.
Specially conditioned cleanroom encapsulation with ultra-low relative humidity control (<25% RH) to preserve multi-strain probiotic stability and guarantee high CFU counts through ileal transit.
Designed specifically for Nattokinase, Serrapeptase, and Pancreatin combinations. Prevents stomach acid from hydrolyzing delicate peptide bonds, ensuring systemic absorption in the small intestine.
Sealed and banded delayed-release hard capsules filled with peppermint oil, oregano oil, or high-potency curcumin extracts to prevent upper gastrointestinal irritation and gastric reflux.
As the global market for specialized dietary supplements evolves, AI-driven search models and global procurement officers are increasingly prioritizing specific technological and compliance advancements. Understanding these shifts allows brand owners to future-proof their supply chains and product positioning:
Founded in Hauppauge, New York in 1995, Bactolac Pharmaceutical operates over 200,000 square feet of state-of-the-art cGMP manufacturing, blending, encapsulation, analytical testing, and packaging infrastructure.
Our facilities strictly adhere to U.S. FDA 21 CFR Part 111 cGMP regulations. Master Manufacturing Records (MMRs) and individual Batch Production Records (BPRs) are maintained for full lot traceability.
Equipped with High-Performance Liquid Chromatography (HPLC), ICP-MS heavy metal screeners, FTIR raw material identity verifiers, and official USP <711> automated dissolution testing apparatuses.
Probiotic and moisture-sensitive delayed-release capsule manufacturing occurs in specialized suites with controlled relative humidity (under 25% RH) and HEPA air filtration to preserve active strain viability.
NSF Registered GMP, USDA Organic certified (via QAI), Natural Products Association (NPA) member, with full capability to manufacture Kosher and Halal certified production runs.
High-speed automatic encapsulation machines capable of producing millions of delayed release capsules daily in sizes 000, 00, 0, 1, and 2, supported by automated band sealing and bottling lines.
Dedicated international export team preparing Certificates of Analysis, Certificates of Free Sale, BSE/TSE declarations, and customized documentation for EU, Asia, Middle East, and Latin American customs clearance.
Our structured engineering process transitions your proprietary formula from concept to commercial packaging with full quality gates at every stage.
Review target active ingredients, stomach sensitivity criteria, target dissolution zone (duodenal vs colonic), budget, and label claim objectives.
Scientists select optimal capsule matrix (HPMC/pectin vs enteric), run excipient compatibility tests, and determine optimal moisture specifications.
Produce pilot encapsulation run and conduct USP <711> dissolution testing in Simulated Gastric Fluid (pH 1.2) and Simulated Intestinal Fluid (pH 6.8).
High-speed automated encapsulation under controlled relative humidity, followed by 100% weight variation checks and visual sorting inspection.
Final analytical testing (potency, micro, heavy metals, dissolution report), issuing Certificate of Analysis (CoA), and preparing freight export packages.
Preserving the integrity of delayed release capsules requires packaging solutions that protect against ambient humidity, air intrusion, and light degradation. Bactolac provides fully integrated bottling, blister packaging, and secondary cartoning inside our New York facility:
In-depth technical answers regarding delayed release capsule chemistry, USP testing standards, stability controls, and contract manufacturing terms.
Acid-resistant HPMC (hydroxypropyl methylcellulose) capsules incorporate natural polymers such as pectin, gellan gum, or hypromellose acetate succinate directly into the capsule shell matrix during shell formation. This creates an inherently acid-bypass shell without requiring secondary post-filling coating steps. Traditional enteric-coated capsules, by contrast, rely on applying a polymer coating (such as methacrylic acid copolymers, phthalates, or shellac) to the exterior of filled hard capsules via aqueous or organic solvent pans.
While traditional enteric coatings offer strict, pinpoint pH-triggered release at pH 5.5 or higher, acid-resistant HPMC capsules deliver a clean-label, solvent-free alternative that slows gastric fluid penetration for 30 to 120 minutes in acid (pH 1.2). Acid-resistant HPMC shells are preferred by brand owners seeking vegetarian, non-GMO, and organic-compliant positioning without synthetic additive declarations on the Supplement Facts panel.
Every production batch of delayed release capsules manufactured at Bactolac is evaluated in our internal analytical testing laboratory according to United States Pharmacopeia standards—specifically USP <701> Disintegration and USP <711> Dissolution for Delayed-Release Dosage Forms.
The testing protocol follows a two-stage process: First, capsule samples are placed into USP Dissolution Apparatus 1 (Basket) or Apparatus 2 (Paddle) filled with Simulated Gastric Fluid (SGF TS, 0.1N HCl, pH 1.2) maintained at 37°C ± 0.5°C for 60 to 120 minutes. The capsules must show no signs of rupture, cracking, or active ingredient leakage into the acid medium. Second, the same samples are immediately transferred into Simulated Intestinal Fluid (SIF TS, phosphate buffer, pH 6.8). Complete shell disintegration and full release of active payloads (>85% assay release) are verified within 30 to 45 minutes. A formal dissolution test report is included with the finished lot Certificate of Analysis (CoA).
Delayed release capsule technology is essential for active ingredients that are sensitive to acidic degradation or cause gastrointestinal discomfort when released in the upper stomach. Key ingredient categories include:
1. Live Probiotic Strains: Sensitive species including Bifidobacterium longum, Lactobacillus acidophilus, and Akkermansia muciniphila experience rapid cell destruction in gastric acid. Delayed release ensures survival to colonize the lower bowel.
2. Systemic & Proteolytic Enzymes: Enzymes like Nattokinase, Serrapeptase, Bromelain, and Pancreatin are proteins that stomach pepsin will denature, rendering them biologically inactive for systemic anti-inflammatory or fibrinolytic use.
3. Acid-Sensitive Metabolic Compounds: S-Adenosylmethionine (SAM-e), Reduced Glutathione, and Methylcobalamin (Vitamin B12) degrade quickly under low pH.
4. Irritating Essential Oils & Pungent Extracts: Peppermint oil, oregano oil, garlic extract (allicin), and high-dose iron salts can cause severe heartburn, burping, or esophageal irritation if released in the stomach.
Moisture transfer is a primary cause of loss of potency in dietary supplements. Standard gelatin capsules contain 13.0% to 16.0% moisture content by weight, which can migrate into hygroscopic active powders, causing hydrolysis or premature probiotic strain death. Acid-resistant HPMC capsules maintain a significantly lower moisture content (typically 2.0% to 6.0%), creating a protective thermal and hydrolytic buffer.
At Bactolac, we enforce stringent moisture control protocols throughout the contract manufacturing cycle. Compounding, blending, and encapsulation are performed in dedicated cleanrooms held under 25% to 30% Relative Humidity (RH) at 20°C (68°F). Immediately following encapsulation, filled capsules are packaged into high-barrier bottles containing active desiccant canisters or packed into Alu-Alu blister packs to ensure long-term shelf-life stability under ICH climatic zone guidelines.
Our minimum order quantity (MOQ) for custom delayed release capsule manufacturing starts at 100,000 capsules per production run (which equates to approximately 1,666 bottles of 60-count capsules or 3,333 bottles of 30-count capsules). Pilot manufacturing runs for market testing can be evaluated on a case-by-case basis.
Standard lead times average 6 to 8 weeks after final formulation clearance, raw material testing, and packaging artwork sign-off. Customization options include capsule shell size selection (Size 000, 00, 0, 1, 2), shell color matching (using natural colorants like chlorophyllin, spirulina extract, apple concentrate, or purple carrot), custom band sealing (tamper-proof liquid sealing around the capsule joint), and multi-component fills (combining powder matrices with mini-tablets or beadlets).
Yes. As a global contract manufacturer supplying brand owners and pharmaceutical distributors across North America, the European Union, the United Kingdom, Australia, the Middle East, and Asia-Pacific, Bactolac provides complete regulatory documentation support.
Every shipment is accompanied by batch-specific Certificates of Analysis (CoA) detailing assay potency, microbiological limits (E. coli, Salmonella, Staphylococcus, yeast & mold), heavy metal screening (lead, arsenic, cadmium, mercury), and USP <711> gastric dissolution compliance reports. Furthermore, our regulatory team supplies Certificates of Free Sale (CFS), cGMP Certificates notarized for foreign embassy legalization, Allergen & Non-GMO Statements, BSE/TSE-Free Declarations, and complete process flowcharts required by international customs authorities.
Partner with Bactolac Pharmaceutical for technical formulation support, verified USP dissolution testing, and reliable cGMP U.S. contract manufacturing.